ARCHIVES

Screening Guidelines: When Scientists Can’t Agree, What’s The Press To Do?

This article is from The Cancer Letter archive.

Vol. 24 No. 19 | May 15, 1998

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014

DCT Board Okays Bladder Cancer RFA From Organ Systems Program

June 6, 1986

Clinical Research Program Announcement

February 13, 1981

Omnibus bill recissions would cut $28 million from NCI FY04 budget.

January 9, 2004

In Brief: MD Anderson’s DuBois Named head of Arizona State’s Biodesign Institute

October 5, 2012

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

May 31, 2013